The DEAL Consortium is delighted to announce a transformative Open Access agreement with the global publisher Elsevier.
This milestone agreement will have a profound impact on the landscape of scholarly publishing and research access in Germany.
Under the terms of the five-year agreement, authors from participating institutions across Germany will publish their research in Elsevier's journals as Open Access aricles under a open license retaining their copyright. This includes well-known journal brands such as Cell Press and The Lancet.
In addition to this new publishing opportunity, participating institutions will secure comprehensive reading access to almost the entire Elsevier journal collection hosted on ScienceDirect.
Learn more about the agreement here
Go to the press release